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HIV-affected couples face unique challenges that require access to
information and reproductive services to prevent HIV
transmission to the uninfected partner and offspring while
allowing couples to fulfil their reproductive goals. In regions of
high HIV prevalence in sub-Saharan Africa, HIV-affected couples
require multipurpose prevention technologies (MPTs) to enhance
their reproductive healthcare options beyond contraception and
prevention of HIV/sexually transmitted infections (STIs) to
include assistance in childbearing. The unique characteristics of
the condom and its accepted use in conjunction with safer
conception interventions allow HIV-serodiscordant couples an
opportunity to maintain reproductive health, prevent HIV/STI
transmission, and achieve their reproductive goals while timing
conception. Re-thinking the traditional view of the condom and
incorporating a broader reproductive health perspective of
HIV-affected couples into MPT methodologies will impact
demand, acceptability and uptake of these future technologies.
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Introduction
HIV-serodiscordant couples, ‘a married or cohabiting cou-
ple in which one partner is HIV-infected and the other is
HIV-uninfected’, are an important source of new HIV
infections in sub-Saharan Africa,1,2 where it is estimated
that 23.5 million people are HIV-infected.3 For example, in
Kenya, the national prevalence of HIV infection is esti-
mated at 5.6% with an estimated 260 000 HIV-serodiscor-
dant couples.4 HIV-infected individuals have reproductive
desires that cannot be ignored and they knowingly risk
HIV transmission in order to conceive.5–7 In HIV-serodis-
cordant partnerships in which pregnancy occurs, the risk of
HIV acquisition nearly doubles for the uninfected partner
compared with partnerships in which pregnancy does not
occur.5 Furthermore, providing fertile HIV-infected women
with the possibility of preserving their fertility and a safer
option for conception is empowering given the stigma and
isolation that they may already encounter as a result of
their HIV status, particularly in cultures where reproduc-
tion defines one’s value in society.8–10 The reproductive
desires and intentions of HIV-infected individuals have not
been adequately addressed, particularly in low-resource
environments,11 in relation to decreasing the risk of unin-
tended pregnancy and transmission of HIV, other sexually
transmitted infections (STIs), and resultant infertility.
Infertility is a global public health problem with great
implications, specifically in HIV-affected couples (Fig-
ure 1). Therefore, the reproductive intentions and pro-
longed periods of unprotected intercourse required to
achieve pregnancy among HIV-infected individuals may
reduce the impact of HIV prevention efforts unless com-
prehensive reproductive services, including multipurpose
technologies (MPTs), equally address contraception, child-
bearing desires and prevention of HIV/STIs.12,13 Redefining
our view of the condom as a model MPT with integration
of comprehensive HIV and reproductive care counselling
and education with provision of safer conception strategies
will successfully achieve the goal of prevention.
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At the International Conference on Population Develop-
ment in 1994, the accepted definition of reproductive health,
implied that women and men have the right to be ‘informed
[about] and have access to safe, effective, affordable and
acceptable methods of family planning. . . and appropriate
healthcare services that will enable women to go through
pregnancy and childbirth and provide couples with the best
chance of having a healthy infant.’14 This definition of
reproductive health has shaped and defined the health strat-
egies of various governmental and nongovernmental organi-
sations including that of the World Health Organization’s
(WHO) Department of Reproductive Health and Research.
The vision of WHO’s Reproductive Health and Research
division, which was adopted by United Nations member
states in 2004, is ‘the attainment by all people of the highest
possible level of sexual and reproductive health.’ Their
intent is to conduct and support research initiatives and
develop public health policies that strive for a world in
which women and men ‘have access to sexual and reproduc-
tive health information services.’ This is premised on the
concept of reproductive rights and assurance of choice when
meeting the needs of diverse populations, particularly those
that have been neglected and at risk. The current reproduc-
tive health paradigm addresses universal access in the fol-
lowing five areas: maternal and newborn health, ‘family
planning’ – contraception and infertility services, preventing
unsafe termination of pregnancy, management of reproduc-
tive tract infections and STIs, including HIV, and promo-
Figure 1. 2010 WHO Analysis: prevalence of primary (upper map) and secondary (lower map) sub/infertility among women aged 20–44 reporting
unsuccessful attempts at conception in the prior 5 years. PLoS Med 2012;9:e1001356.
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tion of sexual health. Linking WHO’s sexual and reproduc-
tive health and HIV prevention objectives and programmes
will enhance development of MPTs for the empowerment of
women through the prevention of HIV/STIs and the provi-
sion of reproductive options.
Despite the intention of public health policies that pro-
vide universal access to reproductive healthcare services,
the reproductive desire to have children by HIV-affected
individuals and couples has not been adequately addressed.
Furthermore, access to safe assisted fertility interventions
has been neglected within the global reproductive health
agenda and ‘family planning’ discussions for HIV-serodis-
cordant couples.15 Comprehensive reproductive services for
HIV-affected couples should not only provide contraceptive
services but also fertility services for those desiring children.
According to WHO sexual and reproductive health guide-
lines for women living with HIV/AIDS men and/or women
with HIV/AIDS ‘may be more likely to have difficulty get-
ting pregnant and to request assistance. These women
should be given full support for counselling and advised of
their options, including adoption and assisted reproduc-
tion, if available’.16 Both simple and complex assisted
reproductive techniques, for HIV-affected couples with
underlying infertility or subfertility, can provide a means
for conception that prevents partner transmission. Before
the use of fertility services, healthcare providers should
consider educating and counselling HIV-affected couples
on fertility awareness methods and performing a fertility
evaluation in the couple to assess for underlying infertility,
which may help to direct them to the appropriate repro-
ductive services. Simple fertility methods include timed
vaginal insemination and sperm washing (SW) with intra-
uterine insemination (IUI); and where indicated and eco-
nomically feasible more complex interventions such as
in vitro fertilisation (IVF) with or without intracytoplasmic
sperm injection (ICSI) as HIV prevention interventions. In
HIV-serodiscordant couples, a water-based lubricated male
condom is a critical fertility care technology for safe collec-
tion of semen that avoids sexual HIV transmission in con-
junction with any of the above methods. These
reproductive interventions avoid extended exposure with
unprotected intercourse in couples desiring children.
All of these methods require the consistent use of male
condoms or, if found acceptable, female condoms, which
would decrease the incidence of pregnancy and HIV/STI
transmission. Most importantly, the range of reproductive
methods offered with the consistent use of condoms will
allow HIV-infected men and women the option of choos-
ing the method best suited to their current situation and
reproductive health priority, either for contraception or
safer conception. As a result of rebranding the condom this
presents new motivation to increase consistent condom
use. Overall, options that address the full complement of
reproductive health needs will enhance uptake and accep-
tance of MPT methodologies. Pharmaceutical methods,
such as the use of anti-retroviral therapy in the HIV-in-
fected partner, have been demonstrated to decrease the risk
of sexual HIV transmission.17,18 In addition, anti-retroviral
therapy may be administered to the uninfected partner in
an HIV-serodiscordant relationship during the periconcep-
tion period as pre-exposure prophylaxis.19 A recent report
from the UK has shown that timed unprotected intercourse
along with the use of pre-exposure prophylaxis by the
HIV-uninfected female in the periovulatory period demon-
strated feasibility and decreased the risk of sexual and peri-
natal HIV transmission.20 Hence, safer conception practices
that use either a reproductive or pharmaceutical interven-
tion should be part of the arsenal of options offered to
HIV-serodiscordant couples. MPTs are being developed to
address a complementary component to provide contracep-
tion; however, they can be innovatively modified to address
the needs of safer conception.
Worldwide, the gap in access and provision of reproduc-
tive healthcare services for HIV-infected individuals affects
their quality of life and social status.11 An expanded repro-
ductive health paradigm, which includes MPTs, is needed
to enhance awareness, options, and access to reproductive
services for HIV-affected women and men.
MPTs and safer conception
The MPTs (i.e. anti-retroviral therapy, monoclonal anti-
bodies and contraceptive impregnated gels, rings and bar-
rier devices) in development are not readily available on
the market for high-risk individuals or HIV-serodiscordant
couples to use for prevention of HIV/STIs or in conjunc-
tion with safer conception interventions. None of the pro-
posed products can be used to prevent transmission/
acquisition of STIs while allowing HIV-serodiscordant cou-
ples the option of safely conceiving with safer conception
interventions. The only product that may provide HIV-
serodiscordant couples with the opportunity to fulfil their
reproductive right of childbearing when they desire and
also prevent HIV transmission/acquisition is the condom
(male or female). Furthermore, the proposed and ongoing
preclinical and clinical studies of these MPT products have
yet to evaluate the impact of anti-retroviral therapy, mono-
clonal antibodies and contraceptive agents on the repro-
ductive tract (i.e. impact on sperm, endometrial
environment for implantation and embryo development).
Despite some of the promising evidence supporting the use
of MPTs, their availability, accessibility and acceptability
are still in question. If high-risk individuals and HIV-af-
fected couples are presented with options that meet their
full reproductive and HIV/STI prevention needs, demand
and acceptability will be likely to increase. To ensure a suc-
81ª 2014 Royal College of Obstetricians and Gynaecologists
Reproductive options for HIV-affected couples
cessful platform, the MPT development strategies need to
address prevention, contraceptive and fertility needs of
high-risk individuals and HIV-affected couples.
The state of affairs: reproductive
guidelines for HIV-affected couples
At the beginning of the HIV epidemic in 1985 in the USA,
the Centers for Disease Control and Prevention (CDC) dis-
couraged HIV-infected women from having children
because of the poor prognosis associated with HIV infec-
tion and the risk of perinatal transmission. Advances in
HIV prevention and treatment have allowed HIV-infected
individuals to live longer and pursue their reproductive
goals; as a result there are now recommendations guiding
individuals in this process.21 The American College of
Obstetrics and Gynecology (ACOG) recommends that in
HIV-serodiscordant partnerships with an HIV-infected
man, ‘assisted conception with sperm washing for intra-
uterine insemination or intracytoplasmic sperm injection
may be safer than timed unprotected intercourse with
regard to HIV transmission.’22 Similarly, the American
Society for Reproductive Medicine (ASRM) recommends
that ‘when an affected couple requests assistance to have
their own genetically related child, they are best advised to
seek care at institutions with the facilities that can provide
the most effective evaluation treatment and follow-up.’23
Furthermore, ASRM asserts that in couples with an
HIV-infected man, the use of sperm preparation techniques
coupled with IUI or ICSI have been demonstrated to be
highly effective in preventing seroconversion of HIV-unin-
fected women and offspring.23 In HIV-serodiscordant
couples with an HIV-infected female, timed vaginal insemi-
nation in the periovulatory period is a low-cost fertility
intervention that couples can use to prevent sexual HIV
transmission while attempting conception. A collected
semen sample obtained after either natural coitus with a
water-based lubricated condom or ejaculation into a clean
cup is inseminated with a syringe into the vagina during
the periovulatory period. However, advanced assisted
reproductive techniques may still be indicated in the pres-
ence of underlying infertility.19,24–26 The position state-
ments of these organisations are also in agreement with
that of the European Society of Human Reproduction and
Embryology.27 In Spain, some clinicians endorse timed
unprotected intercourse in HIV-serodiscordant couples
desiring children when the following conditions are met:
an undetectable serum HIV-RNA, anti-retroviral therapy in
the infected partner, absence of genital tract infections, and
a normal fertility evaluation in the couple.28,29 However,
some argue that timed unprotected intercourse should not
be endorsed in high-risk HIV-serodiscordant couples who
wish to conceive. Unprotected sexual intercourse in high-
risk situations when the above conditions cannot be
assured is discouraged; therefore, preconception counsel-
ling, SW-IUI or ICSI are ideal options when the male part-
ner is HIV-infected.30,31 Most recently, there have been
clinical and laboratory innovations resulting in lower cost
IVF interventions, which may be adapted for low-resource
environments.32
Reproductive services in high-resource
countries
The use of assisted reproductive services such as SW-IUI or
IVF should not only be considered as a method of enhanc-
ing fertility or addressing underlying infertility but as a
critical component of the HIV prevention armamentarium
coupled with consistent condom use.33 In the USA, there
have been no reported cases of HIV transmission to the
HIV-uninfected female partner with the use of SW and
ICSI.33,34 Similarly, there have been no reported cases of
HIV transmission with the use of standardised SW-IUI
techniques worldwide.34–36 In high-resource countries
(World Bank classifications), assisted reproductive services
for HIV-affected couples are available and have been deter-
mined to be effective and safe in retrospective studies.37
However, these services are not accessible and/or affordable
to the majority of couples in need, specifically in the public
healthcare arena in low-resource settings.38 HIV-serodiscor-
dant couples receiving assisted reproductive services in
Italy, believed that it was ‘not right to withhold something
as important to procreation [from] people because they
have a disease’8 because it provided a safer alternative to
natural conception, although not risk-free. Overall, couples
living with HIV believe that society has a moral obligation
to help them find solutions that will assist in overcoming
their barriers to access and providing options through
information on safer conception alternatives to natural
conception.8
In the USA, less than 3% of assisted reproductive prac-
tices registered with the ASRM provide services to couples
in whom one or both partners are HIV-infected.23 The lim-
ited access and barriers to services have been attributed to
concerns about transmission to clinical personnel and con-
tamination of gametes and embryos stored on clinical pre-
mises; however, there have been no reported cases of
occupational HIV transmission to personnel, gametes or
embryos in clinical settings that would support limiting
services to HIV-affected couples.23 The current costs of
assisted reproductive services have made it an unattain-
able service for a significant proportion of HIV-affected
couples—in high-, low- and middle-income countries. Cur-
rent estimates in high-income countries can range from US
$10,000 to 17,000 per cycle of advanced assisted reproduc-
tive services and can be as high as US $25,000.39 In
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low- and middle-income countries, the International Feder-
ation for Fertility Services (IFFS) has found that the aver-
age cost is from US $3,000 to 8,000 per cycle, which is
proportionately more expensive based upon GDP values in
these countries.40
Despite evidence supporting a decreased risk of HIV
transmission in serodiscordant partnerships with the use of
safer conception techniques, there are few prospective stud-
ies evaluating the acceptability and feasibility of these meth-
ods among HIV-serodiscordant couples who desire
children, especially in sub-Saharan Africa. Although SW-IUI
represents one of the lower cost options, the CDC has not
changed its recommendation since 1990 against SW-IUI.
The CDC’s position is based on a single reported case of
HIV seroconversion in a woman using improper tech-
niques.41,42 As a result, the use of approved assisted repro-
ductive technology for male HIV-infected serodiscordant
couples has been limited to SW-ICSI in the USA, which has
also limited the availability of these services because of the
high costs and restricted access, particularly in public health
settings. The National Perinatal HIV Hotline and Clinicians
Network (‘The Perinatal HIV Hotline’) as of March 2013
reported only 17 clinics offering IVF and seven offering
SW-IUI to HIV-serodiscordant couples.43 The number of
service providers may be limited as a result of the existing
CDC recommendations. As of 2003, the CDC outlined three
components that must be fulfilled before it would change
its policy statement and consider the endorsement of insem-
ination for HIV-affected couples: expansion of the fol-
low-up of European women inseminated with processed
semen, evaluation of the effectiveness of laboratory tech-
niques for removing HIV from semen, and evaluation of
the transfer of technology of semen processing to non-re-
search settings.42 We believe that the evidence required to
support new policy guidelines endorsing the use of SW-IUI
by the CDC as a safer method of conception for HIV-af-
fected couples already exists; however, the decision has not
been overturned. Global leaders who shape public policy
agendas should reconsider the scientific evidence that could
enhance the provision of safer conception options as MPTs
to HIV-affected couples desiring children.
Reproductive services in sub-Saharan
Africa
The pronatalist nature of many low-resource countries
defines individuals through parenthood and children are
highly valued by cultural norms.44,45 In sub-Saharan Africa,
many HIV-infected women and men express a desire for
children either immediately or in the near future and being
without a child attracts significant stigma.11 HIV-infected
women report that pregnancy and childbirth are ways for
them to regain their sense of womanhood and sexuality,
often making childbearing a high personal priority.46 To
these women, ‘family planning’ is not just prevention and
management of unwanted pregnancy but also planning for
their family with the assistance of their healthcare provider
and the provision of clinical services.45 Therefore, in cultures
where self-worth and identity are inextricably linked to
childbearing, encouraging HIV-affected couples to abstain
from reproduction or to consistently use condoms while not
providing any support and information on options to safely
conceive is unrealistic. Therefore, the incorporation of safer
conception strategies with condoms as an MPT is critical to
addressing reproductive desires, HIV/STI prevention and
contraception depending on the circumstances and repro-
ductive desires of the HIV-infected individual.
In low-resource environments, the cost, availability and
knowledge of assisted reproductive services may limit their
accessibility to HIV-affected couples.38 To date, three
assisted reproductive clinics in Nairobi, Kenya provide safer
conception interventions for HIV-affected couples desiring
children (Dr A. Murage personal communication).
Although timed unprotected intercourse is theoretically an
acceptable intervention because it can be easily adapted
and accepted by healthcare providers and HIV-affected
couples in low-resource environments, there are inherent
challenges to its use and reliability as the only safer concep-
tion option for HIV-affected couples. It may be unethical
to recommend timed unprotected intercourse as a means
of safer conception for high-risk HIV-serodiscordant
couples despite the lack of costs associated with this
method in low-resource environments where adherence to
anti-retroviral therapy and HIV RNA viral load assessments
is not readily available. Furthermore, in HIV-serodiscor-
dant couples in sub-Saharan Africa with underlying infertil-
ity (Figure 1), conception may not occur so unprotected
sexual encounters aimed at achieving conception may be
futile with continued risk of HIV transmission. Other safer
conception interventions require evaluation to expand the
repertoire of services and options available to HIV-affected
couples desiring children. Redefining reproductive health
strategies to include access to fertility services and innova-
tive uses for MPT beyond contraception has the potential
to improve the nature and quality of reproductive services
for women and men worldwide.
Expansion of the reproductive health
paradigm for HIV-affected couples
Closing the reproductive services gap will require an
acknowledgement and support of the reproductive
intentions and fertility desires of HIV-affected couples.47
Therefore, public health agencies, ministries of health, pol-
icy makers, healthcare providers, researchers and donors
must first acknowledge the reproductive intentions as well
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as the associated challenges of preventing HIV transmission
in HIV-serodiscordant couples who desire a biological fam-
ily.13 Closing the gap in clinical services will require inte-
gration of reproductive healthcare services into HIV
prevention interventions along with the development of
evidence-based clinical guidelines for healthcare providers.
These guidelines will expose the research and product gaps
creating a need for MPTs that address multiple reproduc-
tive health needs.
Implementation studies need to be conducted to ensure
that the successful outcomes reported in high-resource set-
tings can be replicated in low-resource environments with
a high HIV prevalence. These studies should evaluate
whether interventions such as consistent condom use with
timed vaginal insemination during the periovulatory period
and SW-IUI are feasible and acceptable to healthcare pro-
viders and HIV-affected couples as components of HIV
prevention interventions. The findings of these studies will
help to define the cadre of best practices for reproductive
fertility services and product demands that will meet the
satisfaction of healthcare providers and HIV-affected cou-
ples. Enhancing the understanding of healthcare providers
around HIV-related stigma may require adoption of new
skills that will create an engaging environment for repro-
ductive discussions and preconception counselling with
HIV-affected couples. These discussions will help facilitate
the continuum of care from preconception to the postpar-
tum period once pregnancy is achieved. Furthermore,
reproductive healthcare training programmes are needed to
effectively enhance the availability and quality of informa-
tion provided to HIV-affected individuals.48 Preservice
training for nurses, clinical officers, medical officers and
community health workers has been critical to the success-
ful scaling up of HIV prevention, care and treatment ser-
vices in low-resource environments.49 Expanding the
perspective of healthcare providers in training on the full
spectrum of ‘family planning’ will have a great impact on
changing the mindset of future generations to improve the
lives of those they serve. In low-resource environments,
public–private partnerships may help to bring technical
expertise, research and equipment, which may improve the
provision of affordable assisted reproductive services50 and
interventions that include innovative MPTs.
Conclusion
An expanded reproductive health paradigm requires rede-
fining the ‘family planning’ vision while embracing the fer-
tility intentions of all women and men, including those
with HIV, who maintain a desire to have children. In an
expanded reproductive health paradigm, fertility evalua-
tions and assisted reproductive services should not only be
considered for the infertile but also for those seeking safer
conception and for HIV prevention. MPT product develop-
ment should focus on the multipurpose nature and charac-
teristics inherent to the condom. Like the condom, new
MPTs should offer: short-term or single use, prevention of
HIV/STIs and subsequent infertility, and unintended preg-
nancy. Providing fertile HIV-infected women with the pos-
sibility of preserving their fertility and a safer option for
conception is empowering given the stigma and isolation
they may already encounter as a result of their HIV status,
particularly in cultures where reproduction defines one’s
value in society. Despite some of the promising evidence
supporting the use of MPTs, their availability, accessibility
and acceptability are still in question. The prospect of an
HIV-uninfected partner and child may be a strong motiva-
tor for uptake of old and new MPTs in the future.
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